1. Home
  2. DTST vs INTS Comparison

DTST vs INTS Comparison

Compare DTST & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data Storage Corporation

DTST

Data Storage Corporation

HOLD

Current Price

$5.07

Market Cap

37.5M

Sector

Technology

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.39

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTST
INTS
Founded
2001
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.5M
24.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
DTST
INTS
Price
$5.07
$0.39
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$4.33
AVG Volume (30 Days)
131.9K
3.1M
Earning Date
11-19-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
8036.56
N/A
EPS
1.89
N/A
Revenue
$25,529,819.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.32
N/A
Revenue Growth
260.19
N/A
52 Week Low
$2.93
$0.19
52 Week High
$5.44
$3.17

Technical Indicators

Market Signals
Indicator
DTST
INTS
Relative Strength Index (RSI) 76.59 45.52
Support Level $5.03 $0.37
Resistance Level $5.07 $0.43
Average True Range (ATR) 0.06 0.05
MACD -0.00 -0.01
Stochastic Oscillator 98.11 13.19

Price Performance

Historical Comparison
DTST
INTS

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: